Merck And Cie Kmg, based in Switzerland, is a pharmaceutical company.
One of their notable products is CALCIUM FOLINATE (CALCIUM LEUCOVORIN), with a corresponding US DMF Number 5261.
Remarkably, this DMF maintains an Active status since its submission on January 23, 1984, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 02, 2018, and payment made on February 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II